Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dalia Vađunec"'
Autor:
Petra Šoštarić, Magdalena Matić, Dalia Vađunec, Zeljka Lucev Vasic, Mario Cifrek, Marco Pirazzini, Ivica Matak
Background and purpose: Recent preclinical studies suggest that botulinum toxin type A (BoNT-A) reduces abnormal muscle tone following its traffic to second order spinal synapses. However, possible consequences of such actions on spinal neuromotor co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0c518e730937ae655268af660df2d8a
https://doi.org/10.22541/au.168490993.39532166/v1
https://doi.org/10.22541/au.168490993.39532166/v1
Autor:
Vid Matišić, Ivan Mikula, Lidija Bach-Rojecky, Dragan Primorac, Vilim Molnar, Bernard Esquivel, Morgan Donaldson, Alen Juginović, Katarina Žunić, Ljubica Boban, Luka Boban, Damir Erceg, Andrea Skelin, Dalia Vađunec, Lara Primorac, Jasmina Ćatić, Ivana Erceg Ivkošić, Borna Arsov
Publikováno v:
Pharmacogenomics
Volume 21
Issue 2
Volume 21
Issue 2
Pharmacogenomics (PGx) is one of the core elements of personalized medicine. PGx information reduces the likelihood of adverse drug reactions and optimizes therapeutic efficacy. St Catherine Specialty Hospital in Zagreb/Zabok, Croatia has implemented
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af7cc4cf8ba4bf7202cc54d618464a79
https://www.bib.irb.hr/1057619
https://www.bib.irb.hr/1057619
Autor:
Lidija Bach-Rojecky, Tomislav Čutura, Dragan Primorac, Katarina Žunić, Dalia Vađunec, Giorgina Gasparini Špoljar, Marin Lozić, Damir Erceg
Publikováno v:
Personalized Medicine
Volume 16
Issue 6
Volume 16
Issue 6
Clinicians are witnessing differences in the doses required for induction and maintenance of anesthesia, as well as prolonged recovery in some patients. Predictable factors like patient characteristics, factors related to the procedure, pharmacologic
Autor:
Dalia Vađunec, Jelena Kurija, Dragan Primorac, Sara Šipicki, Ryan A. Gregg, Ivan Mikula, Lidija Bach-Rojecky, Katarina Žunić
Publikováno v:
Personalized Medicine
Volume 16
Issue 2
Volume 16
Issue 2
Successful pain management requires the delivery of analgesia with minimal risk of adverse drug reactions. Nonsteroidal anti-inflammatory drugs and opioids remain the mainstay of treatment for the majority of patients. Unfortunately, almost 50% of al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06973fb9f28dd8c7bd3007fc70631d49
https://www.bib.irb.hr/1050150
https://www.bib.irb.hr/1050150